Immunovalent Therapeutics is Biotechnology in United States that focus on operator business. Founded in 2016. They cover business area such as operator, harness microfluidic technology, cancer, a microfluidic device, target t-cell population, physician, ease, tumor.
2016
( 8 years old in 2024 )
Operator
-
20 South Sarah Street
Suite 124
Saint Louis, MO 63108
United States
Private
operatorharness microfluidic technologycancera microfluidic devicetarget t-cell populationphysicianeasetumor
* We use standard office opening hours in near Immunovalent Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Immunovalent Therapeutics is Biotechnology business from United States that founded in 2016 (8 years old in 2024), Immunovalent Therapeutics business is focusing on Operator.
Immunovalent Therapeutics headquarter office and corporate office address is located in 20 South Sarah Street Suite 124 Saint Louis, MO 63108 United States.
Immunovalent Therapeutics was founded in United States.
In 2024, Immunovalent Therapeutics is currently focus on operator sector.
Above is snippet of Google Trends for "operator" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Immunovalent Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
